echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hausen introduced first in class oral antifungal drugs

    Hausen introduced first in class oral antifungal drugs

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 17, Scinexis announced the signing of a strategic cooperation agreement with Hausen Pharmaceuticals, granting the latter the exclusive rights to develop and commercialize ibrexafungerp in Greater China (including Hong Kong, Macau and Taiwan).


    Ibrexafungerp is a glucan synthase inhibitor, a first-in-class triterpene antifungal agent, and is considered to be a new class of broad-spectrum oral/injection antifungal drugs.


    This marketing application is mainly based on the positive results of two multi-center, randomized, double-blind, placebo-controlled, phase III VANISH-303 study and VANISH-306 study.


    If approved, Ibrexafungerp will be the first non-azole therapy for vulvovaginal candidiasis in more than 20 years.


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.